The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
<p>Abstract</p> <p>Background</p> <p>Hypermethylation of promotor CpG islands is a common mechanism that inactivates tumor suppressor genes in cancer. Genes belonging to the <it>RASSF</it> gene family have frequently been reported as epigenetically silenced...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/11/1/40 |
id |
doaj-15dfb6cdb5724202bccece1c44412c70 |
---|---|
record_format |
Article |
spelling |
doaj-15dfb6cdb5724202bccece1c44412c702020-11-25T02:45:13ZengBMCMolecular Cancer1476-45982012-06-011114010.1186/1476-4598-11-40The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastomaDjos AnnaMartinsson TommyKogner PerCarén Helena<p>Abstract</p> <p>Background</p> <p>Hypermethylation of promotor CpG islands is a common mechanism that inactivates tumor suppressor genes in cancer. Genes belonging to the <it>RASSF</it> gene family have frequently been reported as epigenetically silenced by promotor methylation in human cancers. Two members of this gene family, <it>RASSF1A</it> and <it>RASSF5A</it> have been reported as methylated in neuroblastoma. Data from our previously performed genome-wide DNA methylation array analysis indicated that other members of the <it>RASSF</it> gene family are targeted by DNA methylation in neuroblastoma.</p> <p>Results</p> <p>In the current study, we found that several of the <it>RASSF</it> family genes (<it>RASSF2</it>, <it>RASSF4</it>, <it>RASSF5</it>, <it>RASSF6</it>, <it>RASSF7</it>, and <it>RASSF10</it>) to various degrees were methylated in neuroblastoma cell lines and primary tumors. In addition, several of the <it>RASSF</it> family genes showed low or absent mRNA expression in neuroblastoma cell lines. <it>RASSF5</it> and <it>RASSF6</it> were to various degrees methylated in a large portion of neuroblastoma tumors and <it>RASSF7</it> was heavily methylated in most tumors. Further, CpG methylation sites in the CpG islands of some <it>RASSF</it> family members could be used to significantly discriminate between biological subgroups of neuroblastoma tumors. For example, <it>RASSF5</it> methylation highly correlated to <it>MYCN</it> amplification and INRG stage M. Furthermore, high methylation of <it>RASSF6</it> was correlated to unfavorable outcome, 1p deletion and <it>MYCN</it> amplification in our tumor material.</p> <p>In conclusion</p> <p>This study shows that several genes belonging to the <it>RASSF</it> gene family are methylated in neuroblastoma. The genes <it>RASSF5</it>, <it>RASSF6</it> and <it>RASSF7</it> stand out as the most promising candidate genes for further investigations in neuroblastoma.</p> http://www.molecular-cancer.com/content/11/1/40 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Djos Anna Martinsson Tommy Kogner Per Carén Helena |
spellingShingle |
Djos Anna Martinsson Tommy Kogner Per Carén Helena The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma Molecular Cancer |
author_facet |
Djos Anna Martinsson Tommy Kogner Per Carén Helena |
author_sort |
Djos Anna |
title |
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma |
title_short |
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma |
title_full |
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma |
title_fullStr |
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma |
title_full_unstemmed |
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma |
title_sort |
rassf gene family members rassf5, rassf6 and rassf7 show frequent dna methylation in neuroblastoma |
publisher |
BMC |
series |
Molecular Cancer |
issn |
1476-4598 |
publishDate |
2012-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Hypermethylation of promotor CpG islands is a common mechanism that inactivates tumor suppressor genes in cancer. Genes belonging to the <it>RASSF</it> gene family have frequently been reported as epigenetically silenced by promotor methylation in human cancers. Two members of this gene family, <it>RASSF1A</it> and <it>RASSF5A</it> have been reported as methylated in neuroblastoma. Data from our previously performed genome-wide DNA methylation array analysis indicated that other members of the <it>RASSF</it> gene family are targeted by DNA methylation in neuroblastoma.</p> <p>Results</p> <p>In the current study, we found that several of the <it>RASSF</it> family genes (<it>RASSF2</it>, <it>RASSF4</it>, <it>RASSF5</it>, <it>RASSF6</it>, <it>RASSF7</it>, and <it>RASSF10</it>) to various degrees were methylated in neuroblastoma cell lines and primary tumors. In addition, several of the <it>RASSF</it> family genes showed low or absent mRNA expression in neuroblastoma cell lines. <it>RASSF5</it> and <it>RASSF6</it> were to various degrees methylated in a large portion of neuroblastoma tumors and <it>RASSF7</it> was heavily methylated in most tumors. Further, CpG methylation sites in the CpG islands of some <it>RASSF</it> family members could be used to significantly discriminate between biological subgroups of neuroblastoma tumors. For example, <it>RASSF5</it> methylation highly correlated to <it>MYCN</it> amplification and INRG stage M. Furthermore, high methylation of <it>RASSF6</it> was correlated to unfavorable outcome, 1p deletion and <it>MYCN</it> amplification in our tumor material.</p> <p>In conclusion</p> <p>This study shows that several genes belonging to the <it>RASSF</it> gene family are methylated in neuroblastoma. The genes <it>RASSF5</it>, <it>RASSF6</it> and <it>RASSF7</it> stand out as the most promising candidate genes for further investigations in neuroblastoma.</p> |
url |
http://www.molecular-cancer.com/content/11/1/40 |
work_keys_str_mv |
AT djosanna therassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT martinssontommy therassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT kognerper therassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT carenhelena therassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT djosanna rassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT martinssontommy rassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT kognerper rassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma AT carenhelena rassfgenefamilymembersrassf5rassf6andrassf7showfrequentdnamethylationinneuroblastoma |
_version_ |
1724763533812432896 |